We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the Securities Act of 1933, as amended. Confidential Portions are marked: [***]...Credit Agreement • February 27th, 2019 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 27th, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED CREDIT AGREEMENT, dated as of December 27, 2018, is by and among ANI PHARMACEUTICALS, Inc., a Delaware corporation (the “Borrower”), the Guarantors (as hereinafter defined), the Lenders (as hereinafter defined) and CITIZENS BANK, N.A., a national banking association, as administrative agent for the Lenders hereunder (in such capacity, the “Administrative Agent”).
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the Securities Act of 1933, as amended. Confidential Portions are marked: [***]Credit Agreement • February 27th, 2018 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 27th, 2018 Company Industry Jurisdiction